Publicaciones en las que colabora con Aleix Prat (2)

2009

  1. Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels

    Annals of Oncology, Vol. 20, Núm. 2, pp. 294-297

2008

  1. Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer

    Annals of Oncology, Vol. 19, Núm. 2, pp. 327-331